Clinical Trials Sponsored by InGeneron, Inc.
Total 36396 results
-
Regeneron PharmaceuticalsRecruitingCongenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)Spain, United Kingdom, United States
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Israel, Malaysia, Australia, Georgia, Turkey, Canada
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Netherlands, Italy
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Australia, Spain, United Kingdom, Canada, Brazil, Mexico, Germany, Ireland, South Africa, France, Israel, Georgia, Turkey, Italy, Poland, Chile, Argentina, Belgium, Czechia, Romania, Greece
-
Regeneron PharmaceuticalsRecruitingFibrodysplasia Ossificans ProgressivaJapan, United States, Korea, Republic of, Spain, France, Australia, United Kingdom, China, Poland, Malaysia, Italy, Finland, Hong Kong, South Africa, Chile, Brazil, Netherlands, Colombia
-
Regeneron PharmaceuticalsRecruitingHeart FailureTurkey, Moldova, Republic of, Hungary, Belgium, Poland, Romania
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
Regeneron PharmaceuticalsRecruitingChronic Kidney Disease (CKD)United States
-
Regeneron PharmaceuticalsRecruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerUnited States, Belgium
-
Regeneron PharmaceuticalsRecruitingSevere Aplastic Anemia (SAA)United States, France, Korea, Republic of, United Kingdom
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (NHL)United States, Korea, Republic of, China, Spain, Japan, United Kingdom, France, Taiwan, Singapore, Italy, Australia, Canada, Germany, Poland
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaJapan, Belgium, United States, Korea, Republic of, Germany, Spain, United Kingdom
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Aggressive B-Cell LymphomaUnited States, Germany, Spain
-
Regeneron PharmaceuticalsActive, not recruitingRelapsed and Refractory Multiple Myeloma (RRMM)United States
-
Regeneron PharmaceuticalsCompletedCD55-deficient Protein-losing Enteropathy | CHAPLEUnited States, Thailand, Turkey
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa, Australia, Austria, Canada, Czechia, France, Greece, Italy, Japan, Ukraine
-
Regeneron PharmaceuticalsCompletedAsthmaUnited States, Spain, France, Germany, Poland
-
Regeneron PharmaceuticalsActive, not recruitingHealthy VolunteersNew Zealand
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsActive, not recruitingNSCLCUnited States, France, Korea, Republic of
-
Regeneron PharmaceuticalsActive, not recruitingGeneralized LipodystrophyUnited States, Peru, Russian Federation, Turkey
-
Regeneron PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and NeckUnited States
-
Regeneron PharmaceuticalsTerminatedCOVID-19United States, Mexico, Romania
-
Regeneron PharmaceuticalsCompletedAdvanced Cutaneous Squamous Cell CarcinomaUnited States, Spain, France, Italy, Australia, Germany, Brazil, Greece
-
Regeneron PharmaceuticalsActive, not recruitingBasal Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Puerto Rico
-
Regeneron PharmaceuticalsAvailablePartial Lipodystrophy | Generalized Lipodystrophy | Monogenic Obesity Due to LEP or LEPR Loss of Function
-
Regeneron PharmaceuticalsNo longer available
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, United Kingdom, Israel, Germany, France
-
Regeneron PharmaceuticalsCompletedRetinopathy of PrematurityUnited States, Bulgaria, Hungary, Russian Federation, Thailand, Turkey, Colombia, Czechia, Korea, Republic of, Romania, Slovakia, Taiwan, Vietnam
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsCompletedParoxysmal Nocturnal HemoglobinuriaUnited Kingdom
-
Regeneron PharmaceuticalsTerminatedNon-alcoholic Steatohepatitis (NASH)Brazil, United States, Puerto Rico, Korea, Republic of, Mexico
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
Regeneron PharmaceuticalsCompletedHealthy | Chronic Stable IllnessUnited States
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Regeneron PharmaceuticalsTerminatedHealthy VolunteerBelgium
-
Regeneron PharmaceuticalsWithdrawnFibrodyplasia Ossificans Progressiva (FOP) | Heterotopic Ossification (HO)
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsCompletedNonproliferative Diabetic RetinopathyUnited States, Germany, Hungary, Japan, Puerto Rico, United Kingdom
-
Regeneron PharmaceuticalsCompletedLow Back PainUnited States, Poland, Canada, Hungary, Denmark, Estonia, Czechia
-
Regeneron PharmaceuticalsCompletedHealthy Volunteers | Birch Pollen AllergyBelgium
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, Canada
-
Regeneron PharmaceuticalsCompletedRespiratory Syncytial Virus InfectionsUnited States, Australia, Bulgaria, Canada, Chile, Denmark, Finland, Germany, Hungary, Netherlands, New Zealand, Panama, Puerto Rico, South Africa, Spain, Sweden, Turkey, Ukraine, United Kingdom
-
Regeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsCompletedGoutUnited States, Taiwan, South Africa, India, Germany, Indonesia
-
Regeneron PharmaceuticalsCompletedOsteoarthritis, Knee | Osteoarthritis, HipUnited States
-
Regeneron PharmaceuticalsCompletedHealthy VolunteersBelgium
-
Regeneron PharmaceuticalsWithdrawnAdvanced MalignanciesUnited States